Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder.

Abstract excerpt

Genotyping patients prior to beginning psychiatric pharmacological therapy can serve to inform practitioners as to each patient's likelihood of therapeutic response and their relative risk of experiencing toxicity and other adverse side effects from certain drugs. Such information could arm physicians with the knowledge they need to make appropriate drug and dosing decisions and avoid the lengthy trial-and-error...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cytochrome P-450 Enzyme System
• Share to Depression
• Share to Pharmacogenetics